Economy

Bitcoin is holding near $78,000, but the proof-of-reserves report due Nov. 3 will test Binance’s recovery claim under scrutiny.

With the Nasdaq 100 in correction and Q3 results due before Monday’s open, Greg Abel’s cash discipline is both a lesson and a question for every investor.

R2 is now Rivian’s top seller, and Q4 looks bigger. Here is why that matters more than the stock’s 52-week low.

VKTX launched SUNRISE on Oct. 14. The clock for a Lilly deal is running faster than the market appreciates.

With $6.1B due by end-2028 and a $3B Sandals deal, the question is whether guidance holds.

With a $72 billion backlog and generator sales up 72%, CAT may be the cheapest entry point into the AI power buildout before earnings reset the price.

DOJ and FTC ended the HSR waiting period on Oct. 21, clearing a key hurdle ahead of an Oct. 29 shareholder vote.

Today’s jobless claims report is the last labour data traders see before the Fed goes quiet ahead of the October 28 decision.

FITB reports before the open Monday as the first major bank of the week, carrying $73 billion in Comerica assets into a credit environment that is quietly deteriorating.

With $139.4 billion in Chinese drug licensing deals this year, the question for healthcare investors is who actually owns the value being created.